Bievres, France

Jacques Lannoy



Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Blevres, FR (2011)
  • Bievres, FR (2007 - 2012)

Company Filing History:


Years Active: 2007-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jacques Lannoy: Innovator in Medicinal Chemistry

Introduction

Jacques Lannoy is a notable inventor based in Bievres, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on heterocyclic compounds. With a total of 3 patents to his name, Lannoy's inventions focus on the development of new therapeutic agents.

Latest Patents

Lannoy's latest patents include derivatives of heterocycles with five members, specifically designed for use as medicaments. These compounds, which include thiazole, oxazole, imidazole, isoxazole, and isoxazoline derivatives, exhibit advantageous pharmacological properties. They are particularly promising for treating neurodegenerative disorders and pain, showcasing Lannoy's commitment to advancing therapeutic options.

Career Highlights

Throughout his career, Jacques Lannoy has worked with prominent companies in the pharmaceutical industry, including Ipsen Pharma and Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.). His work in these organizations has allowed him to contribute to the development of innovative medicinal solutions.

Collaborations

Lannoy has collaborated with esteemed colleagues such as Pierre-Etienne Chabrier De Lassauniere and Dennis Bigg. These partnerships have further enriched his research and development efforts in the field of medicinal chemistry.

Conclusion

Jacques Lannoy's contributions to medicinal chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for new therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…